Australian Clinical Labs Limited (ASX: ACL)
Australia
· Delayed Price · Currency is AUD 3.525
+0.055 (1.59%)
Nov 22, 2024, 1:39 PM AEST
Australian Clinical Labs Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 21, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2017 |
| Market Capitalization | 692 | 503 | 694 | 922 | 686 | - | Upgrade
|
| Market Cap Growth | -27.51% | -27.51% | -24.69% | 34.33% | - | - | Upgrade
|
| Enterprise Value | 974 | 805 | 1,001 | 1,160 | 940 | - | Upgrade
|
| Last Close Price | 3.47 | 2.44 | 3.23 | 3.86 | 2.79 | - | Upgrade
|
| PE Ratio | 28.92 | 21.03 | 19.34 | 5.17 | 11.37 | - | Upgrade
|
| Forward PE | 17.97 | 13.83 | 15.92 | 9.64 | 7.42 | - | Upgrade
|
| PS Ratio | 0.99 | 0.72 | 1.00 | 0.93 | 1.06 | - | Upgrade
|
| PB Ratio | 3.91 | 2.83 | 4.02 | 3.96 | 8.38 | - | Upgrade
|
| P/TBV Ratio | 39.99 | 39.99 | 95.82 | 13.75 | - | - | Upgrade
|
| P/FCF Ratio | 4.52 | 3.29 | 5.08 | 3.51 | 4.75 | - | Upgrade
|
| P/OCF Ratio | 3.15 | 3.15 | 4.83 | 3.24 | 4.46 | - | Upgrade
|
| PEG Ratio | 1.32 | 3.00 | - | - | 0.63 | - | Upgrade
|
| EV/Sales Ratio | 1.40 | 1.16 | 1.44 | 1.17 | 1.45 | - | Upgrade
|
| EV/EBITDA Ratio | 5.10 | 10.55 | 12.56 | 4.05 | 6.80 | - | Upgrade
|
| EV/EBIT Ratio | 15.57 | 12.87 | 15.35 | 4.24 | 7.34 | - | Upgrade
|
| EV/FCF Ratio | 6.36 | 5.26 | 7.32 | 4.41 | 6.51 | - | Upgrade
|
| Debt / Equity Ratio | 1.74 | 1.74 | 1.83 | 1.13 | 3.71 | 3.21 | Upgrade
|
| Debt / EBITDA Ratio | 1.62 | 1.62 | 1.68 | 0.69 | 1.41 | 2.30 | Upgrade
|
| Debt / FCF Ratio | 2.02 | 2.02 | 2.31 | 1.00 | 2.10 | 2.40 | Upgrade
|
| Asset Turnover | 1.19 | 1.19 | 1.16 | 1.79 | 1.52 | 1.89 | Upgrade
|
| Inventory Turnover | 27.72 | 27.72 | 25.32 | 32.71 | 32.71 | 34.66 | Upgrade
|
| Quick Ratio | 0.52 | 0.52 | 0.51 | 0.53 | 0.60 | 0.73 | Upgrade
|
| Current Ratio | 0.64 | 0.64 | 0.62 | 0.63 | 0.71 | 0.83 | Upgrade
|
| Return on Equity (ROE) | 13.84% | 13.84% | 17.79% | 113.46% | 80.04% | 85.58% | Upgrade
|
| Return on Assets (ROA) | 6.67% | 6.67% | 6.75% | 30.79% | 18.82% | 4.44% | Upgrade
|
| Return on Capital (ROIC) | 8.01% | 8.01% | 8.29% | 38.89% | 23.67% | 6.18% | Upgrade
|
| Earnings Yield | 3.46% | 4.76% | 5.17% | 19.34% | 8.80% | - | Upgrade
|
| FCF Yield | 22.12% | 30.42% | 19.70% | 28.51% | 21.04% | - | Upgrade
|
| Dividend Yield | 3.51% | 4.92% | 4.33% | 13.73% | 5.10% | - | Upgrade
|
| Payout Ratio | 83.35% | 83.35% | 269.85% | 13.59% | 69.57% | - | Upgrade
|
| Buyback Yield / Dilution | 0.82% | 0.82% | 0.18% | -32.47% | -4.65% | - | Upgrade
|
| Total Shareholder Return | 4.33% | 5.73% | 4.52% | -18.74% | 0.45% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.